Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
AIDS Research and Human Retroviruses
|
October 27, 2012
HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia
Karen G Hawke, Russell G Waddell, David L Gordon, et al.
Journal of Molecular Biology
|
November 17, 2007
The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties
Azubuike I Okemefuna, Hannah E Gilbert, Kim M Griggs, et al.
Vaccine
|
June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
David L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Journal of Molecular Biology
|
June 10, 2009
Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation
Azubuike I Okemefuna, Keying Li, Ruodan Nan, et al.
The Medical Journal of Australia
|
November 2, 2010
Community-acquired Klebsiella pneumoniae liver abscesses - an "emerging disease" in Australia
James R Anstey, Timothy N Fazio, David L Gordon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 31, 2008
Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H
Abiodun D Ogunniyi, Marcin Grabowicz, Layla K Mahdi, et al.
Viruses
|
May 24, 2020
Efficacy of Lytic Phage Cocktails on <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> in Mixed-Species Planktonic Cultures and Biofilms
Legesse Garedew Kifelew, Morgyn S Warner, Sandra Morales, et al.
Future Microbiology
|
February 4, 2021
Potential for bacteriophage therapy for <i>Staphylococcus aureus</i> pneumonia with influenza A coinfection
Peter G Speck, Morgyn S Warner, Shailesh Bihari, et al.
Vaccine
|
June 22, 2012
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
David L Gordon, Dimitar Sajkov, Richard J Woodman, et al.
Scientific Reports
|
February 12, 2024
Lytic activity of phages against bacterial pathogens infecting diabetic foot ulcers
Legesse Garedew Kifelew, Morgyn S Warner, Sandra Morales, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
AIDS Research and Human Retroviruses
|
October 27, 2012
HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia
Karen G Hawke, Russell G Waddell, David L Gordon, et al.
Journal of Molecular Biology
|
November 17, 2007
The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties
Azubuike I Okemefuna, Hannah E Gilbert, Kim M Griggs, et al.
Vaccine
|
June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
David L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Journal of Molecular Biology
|
June 10, 2009
Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation
Azubuike I Okemefuna, Keying Li, Ruodan Nan, et al.
The Medical Journal of Australia
|
November 2, 2010
Community-acquired Klebsiella pneumoniae liver abscesses - an "emerging disease" in Australia
James R Anstey, Timothy N Fazio, David L Gordon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 31, 2008
Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H
Abiodun D Ogunniyi, Marcin Grabowicz, Layla K Mahdi, et al.
Viruses
|
May 24, 2020
Efficacy of Lytic Phage Cocktails on <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> in Mixed-Species Planktonic Cultures and Biofilms
Legesse Garedew Kifelew, Morgyn S Warner, Sandra Morales, et al.
Future Microbiology
|
February 4, 2021
Potential for bacteriophage therapy for <i>Staphylococcus aureus</i> pneumonia with influenza A coinfection
Peter G Speck, Morgyn S Warner, Shailesh Bihari, et al.
Vaccine
|
June 22, 2012
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
David L Gordon, Dimitar Sajkov, Richard J Woodman, et al.
Scientific Reports
|
February 12, 2024
Lytic activity of phages against bacterial pathogens infecting diabetic foot ulcers
Legesse Garedew Kifelew, Morgyn S Warner, Sandra Morales, et al.
Page
of 8